Ensuring a Robust DNA Analysis and the Best Clinical Interpretation by Generating a High-Quality Data Set

OncoDEEP® Kit enables laboratories to achieve and consistently replicate high-quality sequencing data regarding coverage and sensitivity. Based on analytical performance this Whitepaper assesses the precision of OncoDEEP® Kit while measuring the repeatability and reproducibility.

Combined with a solid BioIT pipeline and clinical interpretation software tools, robust molecular tumor profi ling data enable your lab to successfully identify a broader range of treatment options for patients, all while saving on the costs and burdens associated with outsourcing. By leveraging this innovative technology, labs can streamline the sequencing process, thereby increasing their efficiency as never seen before.

This field is for validation purposes and should be left unchanged.

You may also be interested in these resources

Scientific Application Note

RENAL CANCER In a retrospective analysis, rechallenge with immunotherapy delivered ORR 23% (compared with 37% ORR for first exposure); responses at rechallenge were not restricted to those who had responded at first exposure.

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma IMPORTANCE Several immune checkpoint inhibitors (ICIs) are approved for use in patients with metastatic renal cell carcinoma (mRCC), but the...

Share This